Ingen-Housz-Oro S, de Prost N, Wolkenstein P. Need for Trial Design Change in Epidermal Necrolysis (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Example of Cyclosporine. J Invest Dermatol 2025 Jan 22:S0022-202X(24)03047.
PMID: 39846903